Aye. But realistically we don't have to cure cancer, we just...

Aye. But realistically we don't have to cure cancer, we just need a safer treatment than what is available, with efficacy. And we only need 1 treatment to either be approved, or appear good enough for future approval for BP to take it on. And so far (pending future results) it looks like all 6 candidates fit the bill. All of them individually are worth more than our current MC.

• Hervaxx,
• pd1Vaxx,
• Checkvacc,
• Vaxxinia,
• Oncarlytics,
• Azercel.

I included Checkvacc, because even tho from our perspective it's slowed, you can be absolutely sure that if Vaxxinia proves successful and ends up in the hands of a single player rather than non-exclusive licensing route, there will be other players will want a shot at the other cf33 strain - Checkvacc. Name 1 big pharma that would pass up an opportunity to secure a patented second formula of kaytruda 8yrs ago given the (hypothetical) chance at one.
And then there's whatever professor K's lab spits out. If B cell takes off, he can give us a new drug every 6 months, not including the ones he already has primed for the clinic. That's crazy potential.

0 is looking like a very low probability from where I sit. There needs to be a hell of a lot failures, or the world needs to fall apart bad enough that success won't mean a great deal anyway.